Murray Stahl's NVO Position Overview
Murray Stahl (via Horizon Kinetics Asset Management LLC) currently holds 15.4K shares of Novo Nordisk A/S (NVO) worth $851,772, representing 0.01% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Murray Stahl has maintained a long-term strategic position in NVO, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2013, adding 61.9K shares. Largest reduction occurred in Q1 2014, reducing 61.9K shares.
Analysis based on 13F filings available since 2013 Q2
Murray Stahl's Novo Nordisk A/S (NVO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Novo Nordisk A/S (NVO) Trades by Murray Stahl
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +15,490 | Add 0.00% | 15,480 | $15.50 |
| Q4 2013 | +61,920 | Add 400.00% | 77,400 | $3.70 |
| Q1 2014 | -61,920 | Reduce 80.00% | 15,480 | $22.80 |
| Q4 2014 | +334 | Add 2.16% | 15,814 | $21.18 |
| Q1 2015 | -334 | Reduce 2.11% | 15,480 | $26.68 |
| Q3 2015 | +174 | Add 1.12% | 15,654 | $27.15 |
| Q1 2016 | -80 | Reduce 0.51% | 15,574 | $27.10 |
| Q2 2016 | -94 | Reduce 0.60% | 15,480 | $26.87 |
| Q3 2016 | +94 | Add 0.61% | 15,574 | $20.80 |
| Q1 2017 | -94 | Reduce 0.60% | 15,480 | $17.12 |
| Q1 2019 | +15,482 | Add 0.00% | 15,480 | $26.16 |
| Q1 2024 | -12 | Reduce 0.08% | 15,468 | $128.40 |
| Q3 2024 | +250 | Add 1.62% | 15,718 | $119.07 |
| Q4 2024 | -2 | Reduce 0.01% | 15,716 | $86.02 |
| Q2 2025 | -118 | Reduce 0.75% | 15,598 | $69.02 |
| Q3 2025 | -248 | Reduce 1.59% | 15,350 | $55.49 |
Murray Stahl's Novo Nordisk A/S Investment FAQs
Murray Stahl first purchased Novo Nordisk A/S (NVO) in Q2 2013, acquiring 15,480 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Murray Stahl has held Novo Nordisk A/S (NVO) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Murray Stahl's largest addition to Novo Nordisk A/S (NVO) was in Q4 2013, adding 77,400 shares worth $286,000. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Murray Stahl's firm, Horizon Kinetics Asset Management LLC, owns 15,350 shares of Novo Nordisk A/S (NVO), valued at approximately $851,772. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Novo Nordisk A/S (NVO) represents approximately 0.01% of Murray Stahl's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Murray Stahl's peak holding in Novo Nordisk A/S (NVO) was 77,400 shares, as reported at the end of Q4 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.